The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders - ScienceDirect
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach | SpringerLink
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Antagonists of the kappa opioid receptor - ScienceDirect
Kappa Opioid Receptors Drive the Emotional Component of Chronic Pain | by BrainPost | Medium
Development of κ Opioid Receptor Antagonists | Journal of Medicinal Chemistry
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports
A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) | Neuropsychopharmacology
Major Depressive Disorder and Kappa Opioid Receptor
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Figure 2 from Development of κ opioid receptor antagonists. | Semantic Scholar
PDF) The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Antagonists of the kappa opioid receptor. | Semantic Scholar
Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications
Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography | Translational Psychiatry
Novel kappa opioid receptor antagonist navacaprant significantly reduces depression symptoms: Phase II study
